Evidence map›Paper›PMID 30241145›Full record

ArticleJournal of global oncology2018

Histology and Cytopathology Capacity in the Public Health Sector in Kenya.

Nathan R Brand, Nicholas Wolf, John Flanigan, Richard Njoroge, Alfred Karagu

Abstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathan R BrandNathan R. Brand, Consultant for Leidos Biomedical, Frederick; Nicholas Wolf and John Flanigan, National Cancer Institute, Bethesda, MD; Nathan R. Brand, Columbia University College of Physicians and Surgeons, New York, NY; Richard Njoroge and Alfred Karagu, Ministry of Health; and Alfred Karagu, National Cancer Institute of Kenya, Nairobi, Kenya.
Nicholas WolfNathan R. Brand, Consultant for Leidos Biomedical, Frederick; Nicholas Wolf and John Flanigan, National Cancer Institute, Bethesda, MD; Nathan R. Brand, Columbia University College of Physicians and Surgeons, New York, NY; Richard Njoroge and Alfred Karagu, Ministry of Health; and Alfred Karagu, National Cancer Institute of Kenya, Nairobi, Kenya.
John FlaniganNathan R. Brand, Consultant for Leidos Biomedical, Frederick; Nicholas Wolf and John Flanigan, National Cancer Institute, Bethesda, MD; Nathan R. Brand, Columbia University College of Physicians and Surgeons, New York, NY; Richard Njoroge and Alfred Karagu, Ministry of Health; and Alfred Karagu, National Cancer Institute of Kenya, Nairobi, Kenya.
Richard NjorogeNathan R. Brand, Consultant for Leidos Biomedical, Frederick; Nicholas Wolf and John Flanigan, National Cancer Institute, Bethesda, MD; Nathan R. Brand, Columbia University College of Physicians and Surgeons, New York, NY; Richard Njoroge and Alfred Karagu, Ministry of Health; and Alfred Karagu, National Cancer Institute of Kenya, Nairobi, Kenya.
Alfred KaraguNathan R. Brand, Consultant for Leidos Biomedical, Frederick; Nicholas Wolf and John Flanigan, National Cancer Institute, Bethesda, MD; Nathan R. Brand, Columbia University College of Physicians and Surgeons, New York, NY; Richard Njoroge and Alfred Karagu, Ministry of Health; and Alfred Karagu, National Cancer Institute of Kenya, Nairobi, Kenya.

Funding

CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

purposeHistology and cytopathology services are necessary for cancer diagnosis and treatment. However, the current capacity of Kenya's pathology laboratories is unknown. A national survey was conducted among public sector pathology laboratories to assess their capacity to perform histology, fine-needle aspiration, and bone marrow aspiration.

methodsBetween April and June 2017, we identified all public hospitals that provide pathology services in Kenya. In total, two national and 13 county referral hospitals met the inclusion criteria and were sent a standardized, pretested, self-administered questionnaire.

resultsA total of 11 hospitals (73%) completed the survey. The reported total caseload of histology, fine-needle aspiration, and bone marrow aspiration for 2016 was 26,472. All of the facilities staffed a pathologist and were providing cancer-related diagnostic services. Nine (82%) of the hospitals maintain a register of diagnosed cancer cases, but only one (11%) of those uses an electronic system. Six (55%) of the surveyed hospitals were able to perform histology with a median turnaround time of 14 days. Six (55%) laboratories regularly referred some specimens elsewhere for interpretation, but three of these centers relied on patients for transportation of the specimen to the referral institution. No laboratories were accredited by an external organization; however, 10 (91%) of the laboratories were working toward achieving accreditation, but only for clinical pathology services.

conclusionThis study describes the current status of histology and cytopathology capacity in Kenya's public sector hospitals. It provides useful baseline information needed by the Ministry of Health to develop necessary capacity building and referral-strengthening interventions. A high proportion of hospitals are working to achieve accreditation points toward their commitment to providing quality services to the Kenyan public.

Indexed as

FemaleHumansKenyaPathology, MolecularPublic HealthPublic Sector

Identifiers

PMID30241145
PMCPMC6180785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.